Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Heinonen

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Neurology|August 26, 1998
Selegiline delays the onset of disability in de novo parkinsonian patients. Swedish Parkinson Study GroupS Pålhagen, E H Heinonen, J Hägglund, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletionC Mytilineou, E K Leonardi, P Radcliffe, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 28, 2001
The N-methyl-D-aspartate antagonist memantine has no neuroprotective effect during hypothermic circulatory arrest: a study in the chronic porcine modelJ Rimpiläinen, M Pokela, K Kiviluoma, et al.
Menopause (New York, N.Y.)|February 16, 2012
Effect of aerobic training on menopausal symptoms--a randomized controlled trialJaana M Moilanen, Tomi S Mikkola, Jani A Raitanen, et al.
Journal of Clinical Pharmacology|July 1, 1997
Desmethylselegiline, a metabolite of selegiline, is an irreversible inhibitor of monoamine oxidase type B in humansE H Heinonen, M I Anttila, H L Karnani, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Pharmacokinetics and metabolism of selegilineE H Heinonen, V Myllylä, K Sotaniemi, et al.
Neurology|September 26, 2002
Midlife income, occupation, APOE status, and dementia: a population-based studyT Anttila, E-L Helkala, M Kivipelto, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 30, 2010
Regulation of human skeletal muscle perfusion and its heterogeneity during exercise in moderate hypoxiaIlkka H Heinonen, Jukka Kemppainen, Kimmo Kaskinoro, et al.
Neurology|September 25, 1998
Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysisC W Olanow, V V Myllylä, K A Sotaniemi, et al.
The Journal of Sports Medicine and Physical Fitness|November 10, 2021
Association between cardiorespiratory fitness and metabolic health in overweight and obese adultsEero A Haapala, Tanja Sjöros, Saara Laine, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Neurology|August 26, 1998
Selegiline delays the onset of disability in de novo parkinsonian patients. Swedish Parkinson Study GroupS Pålhagen, E H Heinonen, J Hägglund, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletionC Mytilineou, E K Leonardi, P Radcliffe, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 28, 2001
The N-methyl-D-aspartate antagonist memantine has no neuroprotective effect during hypothermic circulatory arrest: a study in the chronic porcine modelJ Rimpiläinen, M Pokela, K Kiviluoma, et al.
Menopause (New York, N.Y.)|February 16, 2012
Effect of aerobic training on menopausal symptoms--a randomized controlled trialJaana M Moilanen, Tomi S Mikkola, Jani A Raitanen, et al.
Journal of Clinical Pharmacology|July 1, 1997
Desmethylselegiline, a metabolite of selegiline, is an irreversible inhibitor of monoamine oxidase type B in humansE H Heinonen, M I Anttila, H L Karnani, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Pharmacokinetics and metabolism of selegilineE H Heinonen, V Myllylä, K Sotaniemi, et al.
Neurology|September 26, 2002
Midlife income, occupation, APOE status, and dementia: a population-based studyT Anttila, E-L Helkala, M Kivipelto, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 30, 2010
Regulation of human skeletal muscle perfusion and its heterogeneity during exercise in moderate hypoxiaIlkka H Heinonen, Jukka Kemppainen, Kimmo Kaskinoro, et al.
Neurology|September 25, 1998
Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysisC W Olanow, V V Myllylä, K A Sotaniemi, et al.
The Journal of Sports Medicine and Physical Fitness|November 10, 2021
Association between cardiorespiratory fitness and metabolic health in overweight and obese adultsEero A Haapala, Tanja Sjöros, Saara Laine, et al.
Pageof 6